This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Study About Patients Using Copper Intrauterine Device (IUD)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2012 by Egymedicalpedia.
Recruitment status was:  Recruiting
Information provided by (Responsible Party):
Egymedicalpedia Identifier:
First received: February 14, 2012
Last updated: February 28, 2012
Last verified: February 2012
THE AIM OF THE this study is to assess the hemodynamic changes of uterine artery in patients with CIUD induced bleeding by using transvaginal color Doppler indices (uterine artery resistance index and pulsatility index) to prove the relationship between these changes and bleeding in these patient .

Copper Intrauterine Device Induced Bleeding

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Uterine Haemodynamic Changes in Patients With Copper Intrauterine Device Induced Bleeding

Resource links provided by NLM:

Further study details as provided by Egymedicalpedia:

Estimated Enrollment: 100
Study Start Date: January 2012
Estimated Study Completion Date: May 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
copper IUD used

Group I: includes 50 cases using CIUD and complaining of menorrhagia or menometrorrhagia.

Group II: includes 50 cases using CIUD and not complaining of abnormal uterine bleeding.

  Show Detailed Description


Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
primary care clinic, hospital out patient clinic

Inclusion Criteria:

  1. Regularly menstruating women before CIUD insertion.
  2. Age between 18 and 35 years.
  3. Hormonal treatment has not been taken at least two months before the study.
  4. Non steroidal anti-inflammatory drugs has not been taken 24 hours before the examination.

Exclusion Criteria:

  1. Pregnancy.
  2. The presence of pelvic pathology as ovarian cysts, pelvic endometriosis, endometrial polyps or fibrosis.
  3. Present or past history of pelvic inflammatory disease.
  4. Patients on hormonal treatment in the last two months before the study.
  5. Patients on non steroidal anti-inflammatory drugs last 24 hours before the examination.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01541241

Contact: Mohamed SE Elsafty, lecturer 01003922211 ext 002
Contact: Mohamed Elmandouh Mohamed, ass proff

Shoubra Maternity Hospital Recruiting
Cairo, Shoubra, Egypt
Contact: Ayman Abdelazeem elgamal, Resident    010003385499 ext 002      
Contact: Mohamed SE Elsafty, Lecture    01003922211 ext 002      
Principal Investigator: Ayman Abdelazim Elgamal, resident         
Sponsors and Collaborators
Principal Investigator: Ayman Abdelazim Elgamal, Residant Shoubra General Hospital
  More Information

Responsible Party: Egymedicalpedia Identifier: NCT01541241     History of Changes
Other Study ID Numbers: Ayman-1
Study First Received: February 14, 2012
Last Updated: February 28, 2012

Keywords provided by Egymedicalpedia:
Intrauterine contraceptive device (IUD) is one of the most frequently used methods of birth control around the world
Uterine Hemodynamic changes

Additional relevant MeSH terms:
Pathologic Processes
Trace Elements
Growth Substances
Physiological Effects of Drugs processed this record on September 25, 2017